Community

Our community narratives are driven by numbers and valuation.

Value any stock for free in seconds

Get alerts and valuation updates

Participate in discussions

Weekly Picks

RenovoRx

Stock_Research_Today

Community Contributor

Revolutionizing Cancer Treatment

A Precision Approach to Hard-to-Treat Cancers RenovoRx, Inc. (Nasdaq: RNXT), based in Mountain View, California, is a clinical-stage biopharma company taking a new approach to cancer treatment.

View narrative

US$4.20

70.5% undervalued

371.30%

Revenue growth p.a.

20 days ago

Apple

Investingwilly

Community Contributor

Apple: A Dying Star with an Overpriced Valuation

Intro Apple Inc. (AAPL) has long been one of the most beloved stocks in the market, celebrated for its sleek products and loyal customer base.

View narrative

US$177.34

17.7% overvalued

14.68%

Revenue growth p.a.

5 days ago

Avino Silver & Gold Mines

Agricola

Community Contributor

Avino a case for USD$20 per share within 5 years (assuming $3,500 gold, $100 silver and $4 copper).

Full disclosure. I am a shareholder at the time of writing this.

View narrative

CA$26.79

86.0% undervalued

78.01%

Revenue growth p.a.

20 days ago

RENK Group

Chris1

Community Contributor

Riding the Defense Boom RENK Sees Revenue Climb at 15% CAGR by FY 2029

In a renewed political landscape where a Trump administration adopts a more interventionist stance toward Ukraine, the United States sharply increases its military aid—providing advanced tank transmissions, power packs, and suspension systems. This pivot alleviates initial concerns among European allies, but it simultaneously reinforces the imperative for Europe to shore up its own defense capabilities.

View narrative

€69.87

11.0% undervalued

15.00%

Revenue growth p.a.

21 days ago

Load previous narratives

Flutter Entertainment

AnalystConsensusTarget

Consensus Narrative from 24 Analysts

US Expansion, Product Development And Acquisitions Will Create Future Value

Key Takeaways Expansion into the U.S. and new markets aims to drive future revenue growth and strengthen Flutter's geographic presence. Strategic investments in product innovation and cost transformation programs are expected to enhance customer engagement and improve net margins.

View narrative

US$309.58

19.5% undervalued

15.53%

Revenue growth p.a.

19 days ago

NFI Group

AnalystConsensusTarget

Consensus Narrative from 5 Analysts

Record Backlog And Diverse Bus Models Will Drive Production Efficiency

Key Takeaways Strong order backlog and propulsion-agnostic strategy position the company for revenue growth and market share capture across changing demand types. Favorable North American market conditions and strategies to protect margins may enhance future earnings despite trade uncertainties.

View narrative

CA$19.73

24.9% undervalued

17.63%

Revenue growth p.a.

19 days ago

Integral Diagnostics

AnalystConsensusTarget

Consensus Narrative from 15 Analysts

Upgraded MRI Licensing And Merger Synergies Will Fuel Future Success

Key Takeaways Synergies from the Capitol Health merger and regulation changes are expected to boost operating margins and revenue for Integral Diagnostics. Strategic investments and leveraging of teleradiology capabilities aim to optimize costs and support future revenue growth amidst market expansions.

View narrative

AU$3.15

21.7% undervalued

21.86%

Revenue growth p.a.

19 days ago

Just Eat Takeaway.com

AnalystConsensusTarget

Consensus Narrative from 20 Analysts

150 Million Euro Investment And Global App Will Advance Markets

Key Takeaways Divestiture of non-core assets and strategic investments can improve net margins and revenue growth by focusing on profitable segments. Expansions in Europe and new verticals, alongside a unified global app, aim to boost customer engagement and enhance revenue potential.

View narrative

€20.23

4.4% undervalued

5.45%

Revenue growth p.a.

19 days ago

Umicore

AnalystConsensusTarget

Consensus Narrative from 17 Analysts

Cost-saving Measures And IONWAY Investment Will Secure Future Success

Key Takeaways Strategic cost-saving measures and operational efficiency focus aim to improve net margins and enhance long-term earnings despite near-term cash flow impacts. Global footprint and market hedging efforts stabilize cash flows, positioning Umicore for growth in emerging markets amid volatile conditions.

View narrative

€11.07

22.8% undervalued

-37.41%

Revenue growth p.a.

19 days ago

argenx

AnalystConsensusTarget

Consensus Narrative from 16 Analysts

Prefilled Syringe Launch And Pipeline Trials Will Expand Global Reach

Key Takeaways Strong pipeline potential from advanced Phase III and proof-of-concept studies could drive new product approvals and market expansion, boosting revenues. Planned launches and market expansions, including new VYVGART indications, could broaden global market presence and enhance financial health.

View narrative

€680.44

25.5% undervalued

38.63%

Revenue growth p.a.

19 days ago

Nano-X Imaging

AnalystConsensusTarget

Consensus Narrative from 4 Analysts

FDA And CE Mark Approvals Will Open European Imaging Markets

Key Takeaways FDA clearance and European market entry through CE mark approval may significantly enhance Nano-X Imaging's revenue and market presence. Strategic partnerships and advanced technologies are likely to drive higher-margin revenues and reduce manufacturing costs, improving net margins.

View narrative

US$11.75

52.3% undervalued

96.95%

Revenue growth p.a.

19 days ago

GeneDx Holdings

AnalystConsensusTarget

Consensus Narrative from 7 Analysts

Genome Testing And AI Integration Will Unlock New Frontiers

Key Takeaways Expansion in pediatric neurology and new neonatal testing products are key to GeneDx's future revenue growth and increased market penetration. Strategic acquisitions and AI integration aim to enhance platform efficiency and margins, adding value through recurring software revenue streams.

View narrative

US$107.83

34.1% undervalued

16.53%

Revenue growth p.a.

19 days ago

Perpetual

AnalystConsensusTarget

Consensus Narrative from 10 Analysts

Capital Influx And Cost Savings Will Secure Future Flexibility

Key Takeaways The sale of the Wealth Management business will provide capital to reduce debt, enhancing financial flexibility and potentially improving net margins and earnings. Strategic focus on cost savings, new asset management strategies, and international growth is expected to diversify revenues and positively impact earnings.

View narrative

AU$19.02

6.3% undervalued

1.41%

Revenue growth p.a.

19 days ago

Community

Weekly Picks

Revolutionizing Cancer Treatment

Apple: A Dying Star with an Overpriced Valuation

Avino a case for USD$20 per share within 5 years (assuming $3,500 gold, $100 silver and $4 copper).

Riding the Defense Boom RENK Sees Revenue Climb at 15% CAGR by FY 2029

US Expansion, Product Development And Acquisitions Will Create Future Value

Record Backlog And Diverse Bus Models Will Drive Production Efficiency

Upgraded MRI Licensing And Merger Synergies Will Fuel Future Success

150 Million Euro Investment And Global App Will Advance Markets

Cost-saving Measures And IONWAY Investment Will Secure Future Success

Prefilled Syringe Launch And Pipeline Trials Will Expand Global Reach

FDA And CE Mark Approvals Will Open European Imaging Markets

Genome Testing And AI Integration Will Unlock New Frontiers

Capital Influx And Cost Savings Will Secure Future Flexibility

Value any company in seconds

Popular companies

Community

Weekly Picks

Revolutionizing Cancer Treatment

Apple: A Dying Star with an Overpriced Valuation

Avino a case for USD$20 per share within 5 years (assuming $3,500 gold, $100 silver and $4 copper).

Riding the Defense Boom RENK Sees Revenue Climb at 15% CAGR by FY 2029

Community Investing Ideas

US Expansion, Product Development And Acquisitions Will Create Future Value

Record Backlog And Diverse Bus Models Will Drive Production Efficiency

Upgraded MRI Licensing And Merger Synergies Will Fuel Future Success

150 Million Euro Investment And Global App Will Advance Markets

Cost-saving Measures And IONWAY Investment Will Secure Future Success

Prefilled Syringe Launch And Pipeline Trials Will Expand Global Reach

FDA And CE Mark Approvals Will Open European Imaging Markets

Genome Testing And AI Integration Will Unlock New Frontiers

Capital Influx And Cost Savings Will Secure Future Flexibility

Value any company in seconds

Popular companies